RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Cash and cash equivalents

ABBOTT LABORATORIESABT

Market cap
$221.4B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 20247,616+10.44%
Dec 31, 20236,896-30.22%
Dec 31, 20229,882+0.85%
Dec 31, 20219,799+43.30%
Dec 31, 20206,838+77.15%
Dec 31, 20193,860+0.42%
Dec 31, 20183,844-59.14%
Dec 31, 20179,407-49.48%
Dec 31, 201618,620+272.33%
Dec 31, 20155,001+23.09%
Dec 31, 20144,063+16.92%
Dec 31, 20133,475-67.83%
Dec 31, 201210,802+58.56%
Dec 31, 20116,813+86.74%
Dec 31, 20103,648

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)